FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3136264608> ?p ?o ?g. }

• W3136264608 abstract "Background: Systemic autoinflammatory diseases (SAID) are rare inherited disorders involving genes regulating innate immune signaling and are characterized by periodic or chronic multi-systemic inflammation. Objective: To describe spectrum of clinical, immunological, molecular features, and outcomes of patients with SAID in India. Methods: Request to share data was sent to multiple centers in India that are involved in care and management of patients with Inborn Errors of Immunity. Six centers provided requisite data that were compiled and analyzed. Results: Data on 107 patients with SAID were collated—of these, 29 patients were excluded due to unavailability of complete information. Twelve patients (15%) had type 1 interferonopathies, 21 (26%) had diseases affecting inflammasomes, 30 patients (41%) had non-inflammasome related conditions and 1five patients (19%) had Periodic Fever, Aphthous Stomatitis, Pharyngitis, Adenitis (PFAPA). Type1 interferonopathies identified in the cohort included patients with Deficiency of Adenosine Deaminase 2 ( DADA2) (six patients; five families); STING-associated vasculopathy infantile-onset (SAVI) (three patients, one family); Spondyloenchondro-dysplasia with Immune Dysregulation (SPENCD) (two patients). Diseases affecting inflammasomes include Mevalonate Kinase Deficiency (eight patients); Cryopyrin-Associated Periodic Syndromes (CAPS) (seven patients); NLR Family, Pyrin domain-containing 12 ( NLRP12) (two patients); Familial Mediterranean fever (FMF) (two patients); Autoinflammation and PLCG 2 -associated antibody deficiency and immune dysregulation (APLAID) (two patients). TNF receptor-associated periodic syndrome (TRAPS) (three patients); A20 haploinsufficiency (four patients); Deficiency of Interleukin 1 Receptor Antagonist (DIRA) (two patients) were categorized as non-inflammasome related conditions. There were significant delays in diagnosis Corticosteroids and other immunosuppressive agents were used for treatment as anti-IL-1 drugs and other biological agents were and still are not available in India. Eight (16.3%) patients had so far succumbed to their illness. Conclusions: This is the first nationwide cohort of patients with SAID from India. Clinical manifestations were diverse. Overlapping of clinical features with other relatively common rheumatological disorders often resulted in delays in diagnosis. More nationwide efforts are needed to enhance awareness of SAID among health care professionals and there is an urgent need to make targeted immunotherapies universally available." @default.
• W3136264608 created "2021-03-29" @default.
• W3136264608 creator A5001265682 @default.
• W3136264608 creator A5004437953 @default.
• W3136264608 creator A5006220483 @default.
• W3136264608 creator A5010802969 @default.
• W3136264608 creator A5011722048 @default.
• W3136264608 creator A5014368754 @default.
• W3136264608 creator A5014796722 @default.
• W3136264608 creator A5019441772 @default.
• W3136264608 creator A5022021492 @default.
• W3136264608 creator A5024302751 @default.
• W3136264608 creator A5025477946 @default.
• W3136264608 creator A5035569584 @default.
• W3136264608 creator A5040189077 @default.
• W3136264608 creator A5044929276 @default.
• W3136264608 creator A5053367602 @default.
• W3136264608 creator A5054123086 @default.
• W3136264608 creator A5054255771 @default.
• W3136264608 creator A5055272742 @default.
• W3136264608 creator A5058004973 @default.
• W3136264608 creator A5065283870 @default.
• W3136264608 creator A5072938952 @default.
• W3136264608 creator A5073578557 @default.
• W3136264608 creator A5073620732 @default.
• W3136264608 creator A5083757909 @default.
• W3136264608 creator A5085528417 @default.
• W3136264608 creator A5088442915 @default.
• W3136264608 date "2021-03-19" @default.
• W3136264608 modified "2023-10-13" @default.
• W3136264608 title "Spectrum of Systemic Auto-Inflammatory Diseases in India: A Multi-Centric Experience" @default.
• W3136264608 cites W2018915861 @default.
• W3136264608 cites W2048982572 @default.
• W3136264608 cites W2066593573 @default.
• W3136264608 cites W2146401589 @default.
• W3136264608 cites W2242165656 @default.
• W3136264608 cites W2300808168 @default.
• W3136264608 cites W2514463250 @default.
• W3136264608 cites W2588851103 @default.
• W3136264608 cites W2609326946 @default.
• W3136264608 cites W2613233208 @default.
• W3136264608 cites W2624933871 @default.
• W3136264608 cites W2735680979 @default.
• W3136264608 cites W2737388023 @default.
• W3136264608 cites W2887009202 @default.
• W3136264608 cites W2887250517 @default.
• W3136264608 cites W2900641737 @default.
• W3136264608 cites W2903741683 @default.
• W3136264608 cites W2905819000 @default.
• W3136264608 cites W2907311424 @default.
• W3136264608 cites W2916592009 @default.
• W3136264608 cites W2940679238 @default.
• W3136264608 cites W2944551316 @default.
• W3136264608 cites W2969524520 @default.
• W3136264608 cites W2972681758 @default.
• W3136264608 cites W2979464444 @default.
• W3136264608 cites W2993988745 @default.
• W3136264608 cites W2994935263 @default.
• W3136264608 cites W2995432793 @default.
• W3136264608 cites W3000301584 @default.
• W3136264608 cites W3007016379 @default.
• W3136264608 cites W3007473869 @default.
• W3136264608 cites W3008620558 @default.
• W3136264608 cites W3015703988 @default.
• W3136264608 cites W3033210559 @default.
• W3136264608 cites W3045749034 @default.
• W3136264608 cites W3045899263 @default.
• W3136264608 cites W3048652621 @default.
• W3136264608 cites W3058576493 @default.
• W3136264608 cites W3080530194 @default.
• W3136264608 cites W3083413591 @default.
• W3136264608 cites W3088230064 @default.
• W3136264608 cites W3088985277 @default.
• W3136264608 cites W348933973 @default.
• W3136264608 cites W4231699565 @default.
• W3136264608 doi "https://doi.org/10.3389/fimmu.2021.630691" @default.
• W3136264608 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8017183" @default.
• W3136264608 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33815380" @default.
• W3136264608 hasPublicationYear "2021" @default.
• W3136264608 type Work @default.
• W3136264608 sameAs 3136264608 @default.
• W3136264608 citedByCount "7" @default.
• W3136264608 countsByYear W31362646082021 @default.
• W3136264608 countsByYear W31362646082022 @default.
• W3136264608 countsByYear W31362646082023 @default.
• W3136264608 crossrefType "journal-article" @default.
• W3136264608 hasAuthorship W3136264608A5001265682 @default.
• W3136264608 hasAuthorship W3136264608A5004437953 @default.
• W3136264608 hasAuthorship W3136264608A5006220483 @default.
• W3136264608 hasAuthorship W3136264608A5010802969 @default.
• W3136264608 hasAuthorship W3136264608A5011722048 @default.
• W3136264608 hasAuthorship W3136264608A5014368754 @default.
• W3136264608 hasAuthorship W3136264608A5014796722 @default.
• W3136264608 hasAuthorship W3136264608A5019441772 @default.
• W3136264608 hasAuthorship W3136264608A5022021492 @default.
• W3136264608 hasAuthorship W3136264608A5024302751 @default.
• W3136264608 hasAuthorship W3136264608A5025477946 @default.
• W3136264608 hasAuthorship W3136264608A5035569584 @default.
• W3136264608 hasAuthorship W3136264608A5040189077 @default.
• W3136264608 hasAuthorship W3136264608A5044929276 @default.

• next